↓ Skip to main content

Discovery and resupply of pharmacologically active plant-derived natural products: A review

Overview of attention for article published in Biotechnology Advances, December 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 952)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs
2 blogs
twitter
10010 tweeters
peer_reviews
1 peer review site
facebook
11 Facebook pages
wikipedia
12 Wikipedia pages
googleplus
489 Google+ users
reddit
1 Redditor

Citations

dimensions_citation
332 Dimensions

Readers on

mendeley
926 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Discovery and resupply of pharmacologically active plant-derived natural products: A review
Published in
Biotechnology Advances, December 2015
DOI 10.1016/j.biotechadv.2015.08.001
Pubmed ID
Authors

Atanas G. Atanasov, Birgit Waltenberger, Eva-Maria Pferschy-Wenzig, Thomas Linder, Christoph Wawrosch, Pavel Uhrin, Veronika Temml, Limei Wang, Stefan Schwaiger, Elke H. Heiss, Judith M. Rollinger, Daniela Schuster, Johannes M. Breuss, Valery Bochkov, Marko D. Mihovilovic, Brigitte Kopp, Rudolf Bauer, Verena M. Dirsch, Hermann Stuppner

Abstract

Medicinal plants have historically proven their value as a source of molecules with therapeutic potential, and nowadays still represent an important pool for the identification of novel drug leads. In the past decades, pharmaceutical industry focused mainly on libraries of synthetic compounds as drug discovery source. They are comparably easy to produce and resupply, and demonstrate good compatibility with established high throughput screening (HTS) platforms. However, at the same time there has been a declining trend in the number of new drugs reaching the market, raising renewed scientific interest in drug discovery from natural sources, despite of its known challenges. In this survey, a brief outline of historical development is provided together with a comprehensive overview of used approaches and recent developments relevant to plant-derived natural product drug discovery. Associated challenges and major strengths of natural product-based drug discovery are critically discussed. A snapshot of the advanced plant-derived natural products that are currently in actively recruiting clinical trials is also presented. Importantly, the transition of a natural compound from a "screening hit" through a "drug lead" to a "marketed drug" is associated with increasingly challenging demands for compound amount, which often cannot be met by re-isolation from the respective plant sources. In this regard, existing alternatives for resupply are also discussed, including different biotechnology approaches and total organic synthesis. While the intrinsic complexity of natural product-based drug discovery necessitates highly integrated interdisciplinary approaches, the reviewed scientific developments, recent technological advances, and research trends clearly indicate that natural products will be among the most important sources of new drugs also in the future.

Twitter Demographics

The data shown below were collected from the profiles of 10,010 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 926 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 5 <1%
India 3 <1%
Mexico 3 <1%
Germany 2 <1%
Brazil 2 <1%
Serbia 2 <1%
Austria 1 <1%
Namibia 1 <1%
China 1 <1%
Other 14 2%
Unknown 892 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 184 20%
Student > Ph. D. Student 176 19%
Researcher 125 13%
Student > Bachelor 112 12%
Student > Doctoral Student 74 8%
Other 255 28%
Readers by discipline Count As %
Agricultural and Biological Sciences 235 25%
Chemistry 173 19%
Biochemistry, Genetics and Molecular Biology 119 13%
Pharmacology, Toxicology and Pharmaceutical Science 117 13%
Unspecified 116 13%
Other 166 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 4479. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 September 2018.
All research outputs
#52
of 12,284,660 outputs
Outputs from Biotechnology Advances
#1
of 952 outputs
Outputs of similar age
#1
of 242,035 outputs
Outputs of similar age from Biotechnology Advances
#1
of 11 outputs
Altmetric has tracked 12,284,660 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 952 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,035 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.